These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

38 related articles for article (PubMed ID: 30242449)

  • 1. Correction to: Complement in the pathogenesis of Alzheimer's disease.
    Paul Morgan B
    Semin Immunopathol; 2018 Sep; 40(5):517. PubMed ID: 30242449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between complement factor C3, APOE ε4, amyloid and tau in Alzheimer's disease.
    Bonham LW; Desikan RS; Yokoyama JS;
    Acta Neuropathol Commun; 2016 Jun; 4(1):65. PubMed ID: 27357286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alzheimer's disease plaques and tangles: cemeteries of a pyrrhic victory of the immune defence network against herpes simplex infection at the expense of complement and inflammation-mediated neuronal destruction.
    Carter CJ
    Neurochem Int; 2011 Feb; 58(3):301-20. PubMed ID: 21167244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alzheimer's disease: the problem of incorrect clinical diagnosis.
    McDaniel LD; Lukovits T; McDaniel KD
    J Geriatr Psychiatry Neurol; 1993; 6(4):230-4. PubMed ID: 8251052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma Complement factor H in Alzheimer's Disease.
    Williams MA; Haughton D; Stevenson M; Craig D; Passmore AP; Silvestri G
    J Alzheimers Dis; 2015; 45(2):369-72. PubMed ID: 25589717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement activation as a biomarker for Alzheimer's disease.
    Aiyaz M; Lupton MK; Proitsi P; Powell JF; Lovestone S
    Immunobiology; 2012 Feb; 217(2):204-15. PubMed ID: 21856034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Molecular aspects of the pathogenesis and current approaches to pharmacological correction of Alzheimer's disease].
    Kukharsky MS; Ovchinnikov RK; Bachurin SO
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(6):103-114. PubMed ID: 26438898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correction to: The role of melatonin in the onset and progression of type 3 diabetes.
    Song J; Whitcomb DJ; Kim BC
    Mol Brain; 2017 Dec; 10(1):59. PubMed ID: 29221469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insights into the Molecular Mechanisms of Alzheimer's and Parkinson's Diseases with Molecular Simulations: Understanding the Roles of Artificial and Pathological Missense Mutations in Intrinsically Disordered Proteins Related to Pathology.
    Coskuner-Weber O; Uversky VN
    Int J Mol Sci; 2018 Jan; 19(2):. PubMed ID: 29364151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholesterol metabolism, apolipoprotein E, adenosine triphosphate-binding cassette transporters, and Alzheimer's disease.
    Hirsch-Reinshagen V; Wellington CL
    Curr Opin Lipidol; 2007 Jun; 18(3):325-32. PubMed ID: 17495608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using animal models to determine the significance of complement activation in Alzheimer's disease.
    Loeffler DA
    J Neuroinflammation; 2004 Oct; 1(1):18. PubMed ID: 15479474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Recent advances in the studies on Alzheimer's diseases].
    Tsuji S
    Rinsho Shinkeigaku; 1998 Dec; 38(12):983-7. PubMed ID: 10349334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Copper-2 Hypothesis for Causation of the Current Alzheimer's Disease Epidemic Together with Dietary Changes That Enhance the Epidemic.
    Brewer GJ
    Chem Res Toxicol; 2017 Mar; 30(3):763-768. PubMed ID: 28161940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Involvement of the olfactory system in learning and memory: a close correlation between the olfactory deficit and the course of Alzheimer's disease?].
    Yamamoto T
    Yakubutsu Seishin Kodo; 1991 Aug; 11(4):223-35. PubMed ID: 1799095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inherited and Acquired Decrease in Complement Receptor 1 (CR1) Density on Red Blood Cells Associated with High Levels of Soluble CR1 in Alzheimer's Disease.
    Mahmoudi R; Feldman S; Kisserli A; Duret V; Tabary T; Bertholon LA; Badr S; Nonnonhou V; Cesar A; Neuraz A; Novella JL; Cohen JHM
    Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30044434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alzheimer's disease: from molecular pathogenesis to innovative therapies.
    Scarpini E; Cogiamanian F
    Expert Rev Neurother; 2003 Sep; 3(5):619-30. PubMed ID: 19810962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Inflammatory Mediators in the Pathogenesis of Alzheimer's Disease.
    Azizi G; Navabi SS; Al-Shukaili A; Seyedzadeh MH; Yazdani R; Mirshafiey A
    Sultan Qaboos Univ Med J; 2015 Aug; 15(3):e305-16. PubMed ID: 26357550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Links between Alzheimer's disease and diabetes.
    Sun MK; Alkon DL
    Timely Top Med Cardiovasc Dis; 2006 Oct; 10():E24. PubMed ID: 17066144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implications of the kynurenine pathway and quinolinic acid in Alzheimer's disease.
    Guillemin GJ; Brew BJ
    Redox Rep; 2002; 7(4):199-206. PubMed ID: 12396664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ameliorating effect of anti-Alzheimer's drugs on the bidirectional association between type 2 diabetes mellitus and Alzheimer's disease.
    Ahmed AS; Elgharabawy RM; Al-Najjar AH
    Exp Biol Med (Maywood); 2017 Jul; 242(13):1335-1344. PubMed ID: 28534431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.